NCT06943586Recruiting
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing in Patients With Minor Stroke or High Risk TIA (CYP2C19 and Stroke)
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
The purpose of this research study is to explore whether genetic testing can offer a personalized and timely approach to assist physicians in making more informed medication decisions for stroke or high-risk transient ischemic attack (TIA) patients during their hospital stay.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 3 Apr 2025
- Start date
- 9 Apr 2025
- Primary completion date
- 1 Apr 2028
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Stroke
- NCT number
- NCT06943586
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 9 Apr 2025 to the primary completion date, 1 Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- prescribed anticoagulation prior to stroke
- treated with intravenous thrombolysis
- treated with mechanical thrombectomy
Other illness
- diagnosis of atrial fibrillation, valvular heart disease, index stroke due to known hypercoagulability (subset of other determined etiology) or large vessel disease (culprit vessel stenosis of ≥50%)
- missing NIH Stroke Scale score
Who the study is looking for
- Patients 18-89 years of age
- admitted to University of Alabama at Birmingham (UAB) main hospital with symptoms or signs of minor ischemic stroke, or high risk TIA
- eligible to receive dual antiplatelet load (presented to the hospital within 66 hours of last known well)
Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.